Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
I'm in your boat. I retired early in June '15 at age of 62. I hoping for this to hit, not only for the $, but also for the treatment. I would like to spare my family all the issues associated with this horrible disease. I have a wrong family (daughter 12, son 18 and wife 50) so it would be nice to ensure they are taken care of both financially and peace of mind knowing there is a solution to my oncoming mental challenges.
Best of luck and best wishes for all on this Easter Sunday.
Thanks for the update.
Either way should result in a higher share price due to uncertainty being removed.
I just think it's greedy accumulation. Just when everyone gives up....
Thanks dip!
Great read. Some results by May/June and $200m MC...I think he was being modest.
I wouldn't be surprised to see at least a double from here by July 4th.
And supposedly we were on fast track for medical devices. Whatever happen with that?
I'm thinking that Biogen is thinking that there may be some synergy between therapy's for amyloid plaque and sigma 1 receptors. Has anybody run combo trials on the two?
Perhaps the deal with BMS was the hard part and now they are ready to deal with us.
Perhaps the move on Friday, Monday and Tuesday was the result of deal between BMS and Biogen knowing we are next.
Pure speculation on my part, but one never knows.
Looks like stop losses got taken out
Wow! They will do anything to extend their pay checks.
What the FDA should do is not to consider INSPIRE successful UNTIL EACH APPROVED SITE completes at least one procedure.
No point approving something with only a handful of hospitals every attempting the procedure.
The second arm should be an independent study that's runs concurrent with INSPIRE. Two results and two approvals. To say this will not increase the timeline is genuinely misleading. Mark is the only person who believes this. I bet he doesn't even truly believe it.
This company had so much potential. Too bad there were so many missteps.
Even with 4 more conversions we will be lucky to see $4
Good luck to anybody still invested here.
I didn't say anything about excitement. I said Hmmm...like I said last time I saw this Fidelity was involved in a private placement. Private placements is nothing to get excited about. I just find it interesting since it's not a normal everyday occurrence.
Confidential Treatment
Hummm CT order...Last time I saw this happen it was Fidelity taking a major position in a company.
Since April 3rd we traded appx 4.1m shares of which 1M were naked shorts.
Yesterday's stats: 547k traded, 138k were naked. So far this week (3days) over 500k shares were naked shorts
I would think at some point something would have to give.
I wish HFT and Naked shorts and shorting be illegal. What ever happen to supply and demand?
Perhaps Biogen is going to look at a combined therapy using BMS-986168 and A2-73.
At what price $0.02599?
And the traders know this and thus play with the price.
Expecting any significant movement in price before end of June is just setting yourself up for disappointment. It's better to think longer term and be surprised with early news.
My thoughts on what is happening behind the scenes...
It seems like Dan has a lot of free time on his hands (meeting with one investor for a 3 hour lunch, calling an investor and talking for 30 minutes+, etc.). I wonder if a partnership deal is already done with the caveat we receive EMA approval. Perhaps the partner doesn't want to have the deal confirmed publicly without EMA approval....So Dan sits and waits for his team to complete the EMA paperwork and in the meantime he has long lunches, call investors and updates his excel spreadsheet that's tracking his monthly purchases.
I expect some great news over the next several weeks however I don't see any news coming out this week or next. It would seem too contrived to announce major news on eve of SH meeting.
I actually think May would the news on Rhett's and Parkinson's trial.
It will be done soon (by end of June at the latest). I say this because the largest/last hurdle was obtaining EMA approval on the manufacturing facility so it should be relatively easy process (if they know what they are doing) at this point.
Patience I keep telling myself.
LOL. Then let's point our skis downhill and pick up some speed and hit the mogul straight on. It's time for some air
It's April and let's hear the news already. If it doesn't come by last week then I sense the news will not be good. I'm holding either way.
Highest close since July 26th. On July 27th, we had that infamous $3 drop. I think it's only fair now, if tomorrow we shoot up $30. :)
Seriously, it would be nice to close above our recent high of $6.64
I wonder if Bio's will be a safe haven with all the political tension of the last several days?
If there is a buyer(s) today, I doubt they are finish and we may see another pop during the last 15 minutes and witness a large (or 2 or 3) block trades at the close.
In any event this will be the highest close since 7/26/16.
I think many of us here know something!!!
The share price isn't going anywhere because most expected a deal by now so each passing day weak longs capitulate and sell. One day (most likely sooner than I expect) we will hear news that should be fantastic. Until then I don't fret over the slow bleeding because we will achieve greatness. Enjoy buying opportunity here. A four bagger for sure.
Patience
Power - I agree. I just listed what I thought were the two options. I strongly believe (and invested accordingly) that we will see a major collaborative deal with them within 3 months (hopefully a lot sooner). And I wouldn't be surprised to see other BP's out there lurking.
I raised the same question last month. If Rhett's and Parkinson's upcoming trials will have results in 12 weeks, one would think MS. would have a similar fate.
I know, I know, Biogen's testing is not a trial, but they did most likely got results in 12 weeks. So it's one of two things.
1) results of testing are favorable and discussions are on next steps (partnership, buyout, etc) are taking place or
2). Tests results are unfavorable or not meaningful enough to warrant further collaboration and thus Biogen will just fade away with time by lack of acknowledging their existence.
Those should be a safe bet.
Today's trading seems a bit reserved in that we just sit until a sizable offer (>5,000 shares) then it gets hit and we move up a penny.
Someone likes the April 5's and 7.5's
Is that you bourbon or ignats?
I think today we see a close at 6.08 or better then off to the races AH and tomorrow.
All it's going to take is EMA approval. Once our concept is approved then mainstream will acknowledge and attract everyone... that's when we hit $30+.
It looks to me the 50 dma (5.55) held and once it hit the 10 dma (5.77) we picked up steam.
Thanks bourbon. Much appreciated.
That's a bummer. Let's hope we hear something positive soon.
I want thinking a little bit different in that I was (am) hoping either ADXS or AVXL hits first and pour a significant profits into the other plus CYTR, TPIV and IDRA.
My b/e here is 1.97. The June .5 calls have moved ahead of the Sept 1 calls in open interest.
Let's pray they all hit!!
I believe you are right in that Fidelity is lending out their shares. I say that because if it's truly hard to borrow, the interest rate would be higher than 1%.
I've been watching the short shares availability on fidelity for the last week or so and the availability has gone from 153k down to zero (Fidelity states you need to call to obtain availability) so it looks like the cabal is still shorting under 8. Go figure.
What's wrong with ADSX? We are green. Something is not right. LOL.
Thank you Massen.